Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10054105
rs10054105
STARD4-AS1
T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs11084596
rs11084596 		T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs11199879
rs11199879 		C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs11651052
rs11651052
HNF1B
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs148678804
rs148678804 		A 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs1638703
rs1638703
DLEU1
C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs200383755
rs200383755
GATA5
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs200476
rs200476 		A 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs2555019
rs2555019 		C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs2556378
rs2556378
BCL11A
T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs2853677
rs2853677
TERT
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs2981575
rs2981575
FGFR2
A 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs381949
rs381949
CLPTM1L
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs4548546
rs4548546
WDR11
T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs6061244
rs6061244
GATA5
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs6561599
rs6561599
DLEU1 ; RNASEH2B-AS1
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs677394
rs677394
C5orf66
C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs72878024
rs72878024
BET1L ; ODF3
G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs7906649
rs7906649 		G 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs8853
rs8853
TBX3
C 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs9958656
rs9958656
LOC101927548
T 0.700 GeneticVariation GWASCAT Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 30410027

2018
dbSNP: rs17144046
rs17144046 		G 0.700 GeneticVariation GWASCAT A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). 28656603

2017
dbSNP: rs17779457
rs17779457
MOB3B
0.700 GeneticVariation GWASCAT A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. 23376709

2013
dbSNP: rs758937019
rs758937019
KCNK2
0.010 GeneticVariation BEFREE Our results provide evidence that altered expression and function of TREK-1 channel in patients with overactive LUTS could be due to genetic polymorphisms in the pore domains of TREK-1 channel (rs758937019). 30350878

2019
dbSNP: rs775158737
rs775158737
KCNK2
0.010 GeneticVariation BEFREE There was no significant association of rs775158737-GA genotype and rs775158737-A allele with the overactive LUTS, though they were present only in the overactive LUTS group. 30350878

2019